Breast core biopsy – handling and reporting – GUIDELINES – 2004

Publishing Authority: UK National Coordinating Committee for Breast Screening Pathology

Includes:
1.Specimen handling
2.Reporting categories
B1 – Normal tissue
B2 – Benign lesions
B3 – Uncertain malignant potential
B4 – Suspicious
B5 – Malignant
3.Prognostic information
4.Pitfalls in diagnosis

Links:
BMJ Full text: http://jcp.bmj.com/content/57/9/897.long
BMC Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1770422/
Pubmed abstract: https://www.ncbi.nlm.nih.gov/pubmed/15333647

History:
2004 – First published by authors on behalf of UK National Coordinating Committee for Breast Cancer Screening Pathology UK National Coordinating Committee for Breast Screening Pathology and is endorsed by the European Commission working group on breast screening pathology.1
No subsequent revisions to date.

Reference:
ACP Best Practice No. 179. Ellis IO, Humphreys S, Michell M, Pinder SE, Wells CA, Zakhour HD. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment. J Clin Pathol 2004;57:897–902. doi: 10.1136/jcp.2003.010983. Pathref accessibility score 4.

Note: Core biopsy of breast is not addressed in CAP protocol, release date 2016.